Follow Us on Twitter
Immune Report Card®: New Test Matches Patients With Immunotherapies Likely to Work Best | Roswell Park Comprehensive Cancer Center https://t.co/M3a34gfbQG
Proud that OmniSeq has met the rigorous standards needed to become an NCI-MATCH participating lab. Working hard with our colleagues at LabCorp to bring this testing to NCORP sites across the country! https://t.co/qUQTFidjek
OmniSeq Advance "All I Want": https://t.co/NwtMmpXspL via @YouTube
Congratulations to @OmniSeq on launching another innovative new #genomic test! Dr. Carl Morrison, here with team at #ASCO18: “You see a lot of studies that show promise with these additional biomarkers, and we’re testing for them right now.” https://t.co/MiUyvBPVo7
Excellent work being done at UCSD by @Dr_R_Kurzrock to incorporate transcriptomics and clinical trial matching!
"I’m not saying that on the basis of this one trial transcriptomics can become standard of care but the #WINTHER trial definitely suggests transcriptomics should be an important part of additional clinical trials" @Dr_R_Kurzrock
@WIN_Consortium #ASCO18 https://t.co/GSJ7pbu2Cq